Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy

Clinica Chimica Acta

Volumn 421, Issue , 2013, Pages 213-218

  Dähnrich, Cornelia ^a   Komorowski, Lars ^a   Probst, Christian ^a   Seitz Polski, Barbara ^b,f   Esnault, Vincent ^c   Wetzels, Jack F ^d   Hofstra, Julia M ^d   Hoxha, Elion ^e   Stahl, Rolf A ^e   Lambeau, Gérard ^b,f   Stöcker, Winfried ^a   Schlumberger, Wolfgang ^a  

^a Institute of Experimental Immunology   (Germany)

^b CNRS   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d PASTEUR HOSPITAL   (France)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Diagnosis; IMN; MN; PLA2R; PLA2R1; PMN; Theranostics

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4; M TYPE PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECOMBINANT CELL BASED INDIRECT IMMUNOFLUORESCENCE ASSAY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS, MEMBRANOUS; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PHOSPHOLIPASE A2; SENSITIVITY AND SPECIFICITY;

EID: 84876441600     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.03.015     Document Type: Article

References (23)

1. Glassock R.J. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis 2010, 56:157-167.
2. Polanco N., Gutierrez E., Covarsi A., et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 2010, 21:697-704.
3. Glassock R.J. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003, 23:324-332.
4. Cattran D.C., Pei Y., Greenwood C.M., Ponticelli C., Passerini P., Honkanen E. Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 1997, 51:901-907.
5. van den Brand J.A., Hofstra J.M., Wetzels J.F. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2012, 7:1242-1248.
6. Beck L.H., Bonegio R.G., Lambeau G., et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009, 361:11-21.
7. Glassock R.J. The pathogenesis of membranous nephropathy: evolution and revolution. Curr Opin Nephrol Hypertens 2012, 21:235-242.
8. Hofstra J.M., Wetzels J.F. Anti-PLA 2R antibodies in membranous nephropathy: ready for routine clinical practice?. Neth J Med 2012, 70:109-113.
9. Hoxha E., Blöcker I.M., Probst C., et al. Detection of PLA2R specific autoantibodies in patients with idiopathic membranous nephropathy using PLA2R producing HEK293 cells. Report on the 7th Congress on Autoimmunity, Ljubljana, Slovenia 2010.
10. Debiec H., Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011, 364:689-690.
11. Debiec H., Martin L., Jouanneau C., et al. Autoantibodies specific for the phospholipase A(2) receptor in recurrent and de novo membranous nephropathy. Am J Transplant 2011, 10:2144-2152.
12. Hofstra J.M., Debiec H., Short C.D., et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 2012, 23(10):1735-1743.
13. Stahl R., Hoxha E., Fechner K. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 2010, 363:496-498.
14. Qin W., Beck L.H., Zeng C., et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011, 22:1137-1143.
15. Ancian P., Lambeau G., Mattei M.G., Lazdunski M. The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem 1995, 270:8963-8970.
16. Hoxha E., Harendza S., Zahner G., et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011, 26:2526-2532.
17. Schmidt E., Dähnrich C., Rosemann A., et al. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol 2010, 19:458-463.
18. Koy C., Mikkat S., Raptakis E., et al. Matrix-assisted laser desorption/ionization-quadrupole ion trap-time of flight mass spectrometry sequencing resolves structures of unidentified peptides obtained by in-gel tryptic digestion of haptoglobin derivatives from human plasma proteomes. Proteomics 2003, 3:851-858.
19. Hoxha E., Kneissler U., Stege G., et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 2012, 82(7):797-804.
20. Debiec H., Ronco P. Nephrotic syndrome: a new specific test for idiopathic membranous nephropathy. Nat Rev Nephrol 2011, 7:496-498.
21. Wandinger K.P., Saschenbrecker S., Stoecker W., Dalmau J. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011, 231:86-91.
22. Waters P.J., McKeon A., Leite M.I., et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-671.
23. Komorowski L., Teegen B., Probst C., et al. Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2. J Crohns Colitis 2012, [in press].